Manufacturing
Quality, Transparency, Ethics
Common Questions
Manufacturing capabilities :
Quality of the complete manufacturing process and of the finished pharmaceutical product is the most sensitive aspect of the pharmaceutical manufacturing and no prudent and growing company intending to trade in the international market,
can afford to overlook it. Hence, achieving cGMP and RA benchmarks has become mandatory for us at Synapse
Our state of the art, cGMP-compliant formulation manufacturing facilities manufacture a wide range of Orals Capsules and Tablets, Injectables, Ointment & Creams and Powders, Respiratory Products, Biological and Blood Plasma Products. The facilities are equipped for production flexibility and can switch product lines seamlessly, eliminating the need to install additional production lines to meet altered product specifications and market requirements of demand and supply.
ANVISA BRAZIL, INVIMA COLOMBIA, PICS, EUROPEAN UNION (INSPECTION APPLIED)
FOR
ONCOLOGY, ANTIVIRALS, INJECTABLES-GENERAL & CEPHALOSPOSRINS, HORMONES, OSD CEPHA AND GENERAL, OINTMENT/CREAM
WHO-GMP APPROVED FACILITY
FOR
HORMONES, OSD GENERAL & CV/GASTRO, SACHET FILLING CAPABILITIES
EU APPROVED FACILITY
FOR
INJECTABLES- GENERAL, CEPHALOSPORINS , BETALACTAM, STREILE DROPS
WHO GMP APPROVED FACILITY
FOR
BIOLOGICALS AND PLASMA PRODUCTS
PICS APPROVED FACILITY
FOR
TAB/CAPS/DPI/NASAL SPARY /ORAL LIQUIDS
Synapse Pharmatech
Synapse Pharmatech started its journey in the Spring of 2011 as Indian international and representative Office for some leading pharmaceutical companies from Europe and America. Year 2013 was the year that witnessed the ascent of Synapse into Pharmaceutical Manufacturing when our first product SYNALGIN (METAMIZOL INJECTION) was registered in Central America
Today Synapse caters to Worldwide Pharmaceutical Companies through our selective 200 + finished formulations from 6 manufacturing sites approved by EU, USFDA and WHO GMP categories.
